tiprankstipranks
Trending News
More News >
CStone Pharmaceuticals (HK:2616)
:2616
Hong Kong Market

CStone Pharmaceuticals (2616) Similar Stocks

Compare
4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
CStone Pharmaceuticals
HK$6.02
HK$8.75B
-18.74
147.46%
1 Buy
0 Hold
0 Sell
Moderate Buy
Alphamab Oncology
HK$11.22
HK$10.63B
42.78
230.00%
2 Buy
0 Hold
0 Sell
Moderate Buy
HBM Holdings Ltd.
HK$13.19
HK$11.78B
17.85
828.87%
0 Buy
0 Hold
0 Sell
Moderate Buy
Jiangsu Recbio Technology Co., Ltd. Class H
HK$4.99
HK$2.43B
-3.39
-39.37%
Abbisko Cayman Limited
HK$13.24
HK$9.17B
47.30
203.67%
4 Buy
0 Hold
0 Sell
Strong Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$9.02
HK$5.59B
145.95
1.81%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2616
CStone Pharmaceuticals
5.84
3.48
147.46%
HK:9966
Alphamab Oncology
11.22
7.82
230.00%
HK:2142
HBM Holdings Ltd.
13.19
11.77
828.87%
HK:2179
Jiangsu Recbio Technology Co., Ltd. Class H
4.99
-3.24
-39.37%
HK:2256
Abbisko Cayman Limited
13.24
8.88
203.67%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
9.02
0.16
1.81%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts